Skip to content
Parakho

Jagsonpal Pharmaceuticals Ltd

NSE JAGSNPHARMBSE 507789

Q1 FY27, unaudited

Revenue
₹82.23 Cr
Profit after tax
₹13.19 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations82.23+8.76%287.23
Other income2.83+0.28%12.00
Total income85.07+8.45%299.22
Employee benefit expense22.78+17.16%70.74
Finance costs0.25−1.18%1.03
Depreciation & amortisation2.14−8.97%9.44
Total expenses67.39+5.28%239.62
Profit before tax17.68+22.51%57.52
Tax expense4.49+23.51%14.44
Profit after tax13.19+22.18%43.08
Total comprehensive income13.28+22.40%43.45
Earnings per share
Earnings per share, basic₹2.00₹6.40
Earnings per share, diluted₹1.98₹6.31

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q1 FY27

Jagsonpal Pharmaceuticals reported Q1 FY27 revenue growth of about 9% year-on-year to Rs.82 crores, with operating EBITDA up around 21% to close to Rs.19 crores and PAT up 22% to Rs.13 crores. The company completed an 85% stake acquisition in Aequitas Healthcare for Rs.20.8 crores, giving it entry into the hospital pharmaceutical segment, and also completed a Rs.40 crores share buyback during the quarter. Management described organic growth initiatives around brand-building, productivity improvement, and portfolio shift toward semi-chronic and specialty therapies.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 53 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 24 Aug 2026.